Fig. 5From: Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylationMGMT promoter methylation status is associated with both progression-free survival and overall survival in this cohort by Kaplan–Meier analysis. (Methylated, green; Unmethylated, blue, N = number of patients at time 0, Med = median survival)Back to article page